E-Selectin Nasal Spray to Prevent Stroke Recurrence

NCT00012454 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Cerebrovascular Accident
Transient Ischemic Attack

Interventions

DRUG: E-Selectin nasal spray

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)